About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Webinar on Chinese IP Framework | Main | Webinar on Patent Prosecution in India and China »

March 02, 2019

Webinar on Obvious-Type Double Patenting and PTEs

Strafford #1Strafford will be offering a webinar entitled "Obvious-Type Double Patenting and PTEs After Breckenridge Pharmaceutical and Ezra Ventures LLC Decisions" on March 14, 2019 from 1:00 to 2:30 pm (EDT).  Thomas L. Irving, Adriana L. Burgy, and Jill K. MacAlpine of Finnegan Henderson Farabow Garrett & Dunner will guide IP counsel for understanding double patenting, analyze recent court treatment, including two significant Federal Circuit decisions, offer best practices to defeat double patenting rejections and avoid terminal disclaimers, and provide specific language to consider if a terminal disclaimer must be filed.  The webinar will review the following issues:

• What is the scope of double patenting?
• How do the two recent Federal Circuit decisions impact the scope?
• What steps can be taken to defeat double patenting rejections?
• What are best practices to avoid terminal disclaimers?
• How can practitioners craft terminal disclaimers with an eye towards patent litigation?

The registration fee for the webcast is $347.  Those interested in registering for the webinar, can do so here.

Posted at 11:46 PM in Conferences & CLE's |

Comments

The comments to this entry are closed.

May 2025

Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Categories

Archives

More...